ISIN | CH0368190739 |
---|---|
Valor Number | 36819073 |
Bloomberg Global ID | CHSRI SW |
Fund Name | UBS ETF (CH) - MSCI Switzerland IMI Socially Responsible (CHF) A-dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | n/a |
Peculiarities |
Current Price * | 17.59 CHF | 14.01.2025 |
---|---|---|
Previous Price * | 17.53 CHF | 13.01.2025 |
52 Week High * | 18.45 CHF | 27.09.2024 |
52 Week Low * | 15.81 CHF | 19.01.2024 |
NAV * | 17.59 CHF | 14.01.2025 |
Issue Price * | 17.59 CHF | 14.01.2025 |
Redemption Price * | 17.59 CHF | 14.01.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 515,878,928 | |
Unit/Share Assets *** | 272,160,649 | |
Trading Information SIX |
YTD Performance | +0.77% |
31.12.2024 - 14.01.2025
31.12.2024 14.01.2025 |
---|---|---|
1 month | -0.03% |
16.12.2024 - 14.01.2025
16.12.2024 14.01.2025 |
3 months | -4.60% |
14.10.2024 - 14.01.2025
14.10.2024 14.01.2025 |
6 months | -2.06% |
15.07.2024 - 14.01.2025
15.07.2024 14.01.2025 |
1 year | +10.25% |
15.01.2024 - 14.01.2025
15.01.2024 14.01.2025 |
2 years | +13.16% |
16.01.2023 - 14.01.2025
16.01.2023 14.01.2025 |
3 years | +0.32% |
14.01.2022 - 14.01.2025
14.01.2022 14.01.2025 |
5 years | +33.44% |
14.01.2020 - 14.01.2025
14.01.2020 14.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Swiss Re AG | 5.43% | |
---|---|---|
UBS Group AG | 5.32% | |
Zurich Insurance Group AG | 5.10% | |
Roche Holding AG | 5.07% | |
Givaudan SA | 5.05% | |
ABB Ltd | 4.94% | |
Novartis AG Registered Shares | 4.89% | |
Alcon Inc | 4.86% | |
Nestle SA | 4.75% | |
Sika AG | 4.51% | |
Last data update | 09.01.2025 |
TER | 0.28% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.28% |
SRRI ***
|
|
SRRI date *** | 31.12.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |